Kaplan–Meier survival analysis correlated gene expression levels with overall survival, associating decreased PIK3CD levels with worse prognosis in breast cancer and elevated CYP19A1 expression with poorer survival in colon cancer. This evidence concerns the gene CYP19A1 and breast carcinoma.